Specific human antibodies for selective cancer therapy

Details for Australian Patent Application No. 2002246737 (hide)

International Classifications

Event Publications

6 February 2003 Application Open to Public Inspection

Published as AU-B-2002246737

27 November 2003 Change of Name(s) of Applicant(s), Section 104

Bio-Technology General Corp. The name of the applicant has been changed to Savient Pharmaceuticals, Inc.

1 March 2007 Application Accepted

Published as AU-B-2002246737

28 June 2007 Standard Patent Sealed

23 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.